Entera Bio Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Entera Bio Ltd. on April 15, 2019, for the month of April 2019. The filing serves to furnish materials related to the company's Annual General Meeting of Shareholders scheduled for May 20, 2019, at its principal executive office in Jerusalem, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing containing meeting notices and proxy materials rather than a financial report.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document focuses solely on the administrative logistics of the upcoming shareholder meeting.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It incorporates by reference the Notice and Proxy Statement (Exhibit 99.1) and Proxy Card (Exhibit 99.2) for the Annual General Meeting.
Key Facts for Investors to Verify
- The Annual General Meeting is scheduled for May 20, 2019, at 5:00 p.m. Israel time.
- The meeting location is Kiryat Hadassah, Minrav Building, Fifth Floor, Jerusalem, Israel.
- Dr. Philip Schwartz, Chief Executive Officer, signed the filing on behalf of the registrant.
- Investors should review the attached Exhibit 99.1 (Notice and Proxy Statement) for specific agenda items and voting proposals not detailed in this cover letter.